Search

everythinglearnresearchcommunity

for

Search:↓

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Dermoscopy and trichoscopy are useful for diagnosing skin signs in Dermatomyositis.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Azelaic acid helps protect hair cells from UV damage and encourages hair growth by increasing certain gene expressions and proteins.

Manipulating cell cleanup processes could help treat hair loss.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.